Stock CAPS CAPSTONE HOLDING CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Capstone Holding Corp.

Equities

CAPS

US14068E2081

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 11:28:02 2024-05-10 am EDT 		5-day change 1st Jan Change
4.625 USD -7.50% Intraday chart for Capstone Holding Corp. -7.50% -11.06%
Apr. 01 Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Capstone Holding Corp. Announces Change in Board of Directors CI

Valuation

Fiscal Period: December 2018 2019 2021 2022 2023
Capitalization 1 0.9789 0.8158 1.368 5.832 0.8196
Enterprise Value (EV) 1 2.113 3.87 29.66 34.61 21.1
P/E ratio -2.58 x -0.39 x 2.43 x -583 x -0.14 x
Yield - - - - -
Capitalization / Revenue 0.49 x - 0.02 x 0.09 x 0.02 x
EV / Revenue 1.06 x - 0.44 x 0.56 x 0.44 x
EV / EBITDA -88 x -5.35 x 5.91 x 8.17 x -22.2 x
EV / FCF 260 x 3 x - -9.3 x 8.61 x
FCF Yield 0.38% 33.3% - -10.7% 11.6%
Price to Book -0.79 x -0.25 x 0.22 x 0.71 x 0.34 x
Nbr of stocks (in thousands) 54.4 54.4 79.3 158 158
Reference price 2 18.00 15.00 17.25 37.00 5.200
Announcement Date 3/22/19 3/27/20 3/30/22 3/30/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2021 2022 2023
Net sales 1 2 - 66.74 61.56 48.35
EBITDA 1 -0.024 -0.723 5.022 4.234 -0.95
EBIT 1 -0.181 -0.762 4.636 3.993 -1.256
Operating Margin -9.05% - 6.95% 6.49% -2.6%
Earnings before Tax (EBT) 1 -0.432 -1.023 4.357 3.098 -3.585
Net income 1 -0.38 -2.073 3.921 2.315 -3.819
Net margin -19% - 5.87% 3.76% -7.9%
EPS 2 -6.987 -38.12 7.102 -0.0634 -36.39
Free Cash Flow 1 0.008125 1.289 - -3.721 2.449
FCF margin 0.41% - - -6.04% 5.07%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/22/19 3/27/20 3/30/22 3/30/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2021 2022 2023
Net Debt 1 1.13 3.05 28.3 28.8 20.3
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) -47.25 x -4.224 x 5.633 x 6.798 x -21.34 x
Free Cash Flow 1 0.01 1.29 - -3.72 2.45
ROE (net income / shareholders' equity) 35.8% 38.5% - 7.42% -12.2%
ROA (Net income/ Total Assets) -7.43% -54.1% - 3.96% -1.33%
Assets 1 5.116 3.833 - 58.47 286.8
Book Value Per Share 2 -22.90 -60.70 78.70 51.80 15.50
Cash Flow per Share 2 24.70 0.3100 0.6300 0.1500 0.3300
Capex - - 1.17 0.17 0.21
Capex / Sales - - 1.76% 0.28% 0.43%
Announcement Date 3/22/19 3/27/20 3/30/22 3/30/23 4/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CAPSTONE HOLDING CORP. Stock Capstone Holding Corp.
-11.06% 729K
MODERNA, INC. Stock Moderna, Inc.
+29.77% 49.46B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.00% 42.58B
LONZA GROUP AG Stock Lonza Group AG
+50.47% 42.49B
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 29.09B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.68% 26.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.99% 18.64B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.22% 13.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.41% 12.55B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.62% 11.98B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CAPS Stock
  4. Financials Capstone Holding Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW